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Open questions in organic crystal
polymorphism
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Polymorphs, crystals with different structure and properties but the same
molecular composition, arise from the subtle interplay between thermodynamics
and kinetics during crystallisation. In this opinion piece, the authors review the
latest developments in the field of polymorphism and discuss standing open
questions.
Be they medicines, foodstuffs, paints or electronics, many of the products that we consume
contain active crystalline components. The structure and the properties of such crystalline solids
are dictated by intermolecular interactions which bring molecules together in perfectly ordered
symmetric arrangements—crystal structures (Fig. 1)1. The regularity of these structures is
manifest to the naked eye in the form crystallites of regular and symmetric shapes (also known as
crystal habits and morphologies), and their exquisite internal structures can be determined at the
molecular level by techniques such as X-ray diffraction.
Crystallisation is the process by which molecular crystals are produced—with crystallisation
from a liquid solution being the most common in industry. Two steps are involved in crystal-
lisation: (i) nucleation, which is the process leading to the birth of a crystal nucleus and (ii)
growth, which is the process by which molecules get incorporated into such nuclei, leading to
macroscopic crystals. Because intermolecular interactions are soft ‘bonds’ and because molecules
possess shape, the competition between maximum space filling and utilisation of strongest
possible interactions can result in the nucleation and growth of different crystal structures (with
identical composition and similar energies) under different crystallisation conditions (solvent,
composition, purity, temperature, pressure). This phenomenon, known as crystal polymorphism
(Fig. 1), was first noticed almost 200 years ago for inorganic compounds by Mitscherlich and
soon after for organic compounds by the German chemists Liebig and Wöhler2,3. The phe-
nomenon remained a curiosity at the time and was barely studied until, in the late 1960s, its
importance to the development of drugs and other products began to be realised. Because each
polymorph of a given molecule has a unique crystal structure, it would also have its own unique
physical properties (such as mechanical hardness, solubility, colour, melting point etc). To
manufacture and deliver crystalline based consumer products which perform consistently,
therefore, it is vital to control and deliver the same polymorphic form across each batch of
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crystals (Fig. 1). In this context, what have we learnt and what are
the open questions in organic crystal polymorphism?
Molecular basis of polymorphism
Q1 Why are some compounds polymorphic and others not?.
This is perhaps the first fundamental question which remains
open. In some cases, compounds having very similar chemical
structure behave in a completely different manner when it comes
to polymorphism. To our knowledge, 9,10-anthraquinone crys-
tallises in one unique crystal form, phenazine crystallises in two
polymorphs, anthracene in three polymorphs, whilst acridine has
been reported to have at least nine polymorphs (Fig. 2)4. We
know from various databases that between 37–66% of com-
pounds exhibit polymorphism3. The vast majority of poly-
morphic compounds are reported to only have a pair of
polymorphs (89%), 9% three polymorphs and only 2% four
polymorphs or more2. Yet, it remains impossible to know, based
on molecular structure alone, whether a compound will be
polymorphic or indeed how to decide if all possible polymorphs
have been found in experimentation.
Q2 Are polymorphs predictable from molecular structure?. In
the last 20 years or so, there has been enormous progress in the
field of crystal structure prediction (CSP)5. CSP is a computa-
tional technique allowing for the generation of all possible crystal
packings of a given compound. A polymorphic landscape is
produced whereby hundreds of crystal structures are generated
computationally, and their lattice energies calculated. These
landscapes are sometimes successful at predicting the most stable
low temperature crystal structure, if extremely accurate energy
models are used6. Predicting which polymorphs might appear
experimentally, however, still remains a major challenge. The fact
that a crystal structure is generated computationally does not
mean it can be obtained experimentally7 and indeed making the
link between prediction and practical realisation remains an
unsolved, yet vital goal simply because while thermodynamic
stability can be computed from structural information, rate
constants for nucleation and growth cannot yet. However, some
progress is being made here. Increasing evidence is appearing for
the direct link between nucleation and growth rates with fast
growers also being fast nucleators8. In this sense the problem may
reduce to the computation of growth rates for which the litera-
ture is replete with methodologies. Here we mention the simple
attachment energy methodology, the mechanistic models of
Snyder and Doherty9 and most recent work in which surface
rugosity is used as a comparative measure of growth rates10.
Experimental preparation of polymorphs
Q3 Why are some polymorphs so difficult to crystallise?.
Nucleation, the origin of a crystal, is perhaps the least well
understood step in the area of polymorphism. Kinetics and
thermodynamics play a fine game in nucleation and crystal
growth of various polymorphs. For example, theophylline form
IV, despite being the most thermodynamically stable polymorph,
is extremely difficult to crystallise because it is hard to nucleate
and grows much slower than the common form II11. Ostwald’s
Fig. 1 Supramolecular assembly evolution of p-aminobenzoic acid (pABA) from a single molecule into crystallites of two different polymorphs. The
assembly occurs via two different routes (pink and blue) as a consequence of two different types of crystallisation conditions (X and Y), which leads to













Fig. 2 Similar compounds can behave very differently when it comes to
polymorphism. Molecular structure, Cambridge Structural Database six-
letter family refcode and number of polymorphs for anthracene, phenazine,
9,10-anthraquinone and acridine.
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rule of stages, with its central tenet that metastable forms will
always appear first, has provided a useful experimental guide to
the kinetics of solution crystallisation processes12. However,
recently the rule has been shown to be only a special case of a
much bigger experimental landscape, the details of which are
currently beyond computation. Gaining a better understanding of
the kinetics of crystal nucleation and growth for a wide range of
polymorphic systems13 is thus a must if we are able to establish
better links between crystal forms and the conditions that afford
them. Beyond detailed kinetic studies, the community would
benefit from abundant and accurate reports of exact crystal-
lisation conditions that lead to new polymorphs. The problem
here, however, lies in the fact that often the presence of small
amounts of impurities may play an important role. As a con-
sequence, reports of irreproducibility of polymorphic observa-
tions or of disappearing polymorphs abound not only across labs
but also within one’s own14. Another aspect to consider in the
crystallisation of polymorphs is the conformational problem
whereby polymorphs with high energy conformers have been
found to be very difficult to produce2. Other polymorphs cannot
be nucleated directly from solution but have to be produced via
desolvation of intermediate solvates15 or through
mechanochemistry16.
Q4 Do polymorphs change stability under different condi-
tions?. Most CSP landscapes only illustrate the system state at
one unique set of conditions, usually 0 K and no external pres-
sure. Polymorphs, however, are known to change in stability with
conditions such as temperature, pressure and even particle size17.
Therefore, the generation, understanding and prediction of phase
diagrams under a number of conditions is an area that deserves
careful further consideration within the context of polymorph-
ism. In recent years, a number of approaches have been devel-
oped for the computation of crystal free energies18 (beyond
lattice energies) but these remain computationally expensive.
Similarly, exploring polymorph stabilities experimentally with
pressure may lead to stability changes between forms and the
realisation of new polymorphs19. Finally, polymorph stability
changes as a function of crystal size have rarely been studied
although this has been shown to be important in the context of
mechanochemistry17 and crystallisation in nanoconfinement20.
Q5 Can the crystallisation of polymorphs be directed by
templating?. Many polymorphs can only be obtained by crys-
tallisations in the presence of other compounds either in solu-
tion, with solid polymers21 or crystallisation within gels22.
Growing compounds onto isostructural (or mixed) seeds of
related analogues has been proven as a way to produce some
predicted forms but only in a handful of examples including
form V carbamazepine23 and ROY24. When such templating
strategies are possible and how to achieve them remain open
questions.
Characterisation of polymorphs
Q6 Are we able to detect and determine all polymorphs?.
Despite advances in instrumentation over the last 50 years often
compounds, especially large flexible pharmaceuticals, are difficult
to crystallise as single crystals amenable to X-ray diffraction. In
those cases, structure solution from powders or from a combi-
nation of methods may be the only possibility. In recent years,
there has been some development in electron diffraction tech-
niques which are able to solve complex structures, and even
determine absolute configurations, from crystals of just a few
hundreds of nm in size25. These techniques are still in need of
further development so that they may be used more routinely in
solid-state labs around the world. Related to this, tiny amounts of
other polymorphs may be present in final products but are not
detectable with current analytical techniques26. Increased sensi-
tivity of analytical methods at the lab scale is therefore required,
though this remains an issue of characterisation of materials in
general. Finally, it is possible for true polymorphs to have very
similar structures to the extent that that they may be overlooked
experimentally, having only subtle differences in the X-ray dif-
fraction patterns. Hence expert use of a combination of structural
analysis techniques will be important in the future to uncover the
true extent of polymorphism27.
Structural basis for physical properties of polymorphs
Q7 Do crystal dynamics, defects and disorder effect polymorph
properties?. The notion of an idealised perfect crystal is only true
in theory. Real crystals are full of defects and many also have
structural disorder. Beyond our average static view of crystals
(averaged positions determined by XRD often at low tempera-
tures), molecules are able to vibrate, librate and in some cases
some of their groups are able to rotate (i.e. methyl group rota-
tions or pedal motions). Our view of crystals and polymorphs is
too static and to be able to better understand and model disorder
or entropic contributions to free energies, we need to move
towards a better understanding of crystal dynamics. This may
require of further experimental data on high temperature struc-
tures and their dynamics as well as dynamic simulations of
crystals. Disorder can manifest in many ways. It can be static or
dynamic positional disorder of parts of the molecule within the
unit cell, as well as more macroscopic phenomena such as
mosaicity, twinning or stacking faults possibly also with loss of
order at the crystal surfaces28,29. Each of these will have a precise
effect on the physical properties of ‘real’ crystalline materials yet
they remain difficult to characterise experimentally and model
computationally even by expert practitioners.
Q8 Can we predict structure-property relationships?. We need
to start establishing links between structure and properties in
polymorphs so that we can enable computational prediction30.
For this, first, properties of polymorphs need to be accurately
measured, reported and reviewed. For example, Pudippeddi and
Serajuddin compiled the solubility differences of a large set of
polymorphs revealing solubility ratios between polymorphs is
usually less than 231. In recent years, with the development of
nanoindentation there has been some novel work in trying to link
crystal structure to mechanical properties of crystals32. More
such studies would benefit the field tremendously since ulti-
mately, the exploitation of polymorphs will be determined by
their physical properties.
Outlook
In theory, one would want to generate the polymorphic landscape
of a compound computationally, link it to crystal properties,
retrieve the crystallisation conditions of the desired form and
crystallise it. In practice, computationally generated polymorphic
landscapes are challenging, structure-property relationships are
not yet accurately predictable, we can rarely design crystallisation
conditions for the discovery of specific polymorphic forms and
crystallisation process design remains a challenging engineering
exercise. Whilst we have learnt so much in the last fifty years or
so, many fundamental questions remain open for us to solve in
the coming decades.
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